Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 04:00PM ET
3.40
Dollar change
-0.36
Percentage change
-9.65
%
Index- P/E- EPS (ttm)-1.34 Insider Own18.06% Shs Outstand11.33M Perf Week-6.93%
Market Cap38.73M Forward P/E- EPS next Y-0.85 Insider Trans0.14% Shs Float9.34M Perf Month-32.06%
Income-14.38M PEG- EPS next Q-0.28 Inst Own41.95% Short Float0.45% Perf Quarter-0.96%
Sales42.16M P/S0.92 EPS this Y20.99% Inst Trans-0.49% Short Ratio1.04 Perf Half Y9.58%
Book/sh2.95 P/B1.15 EPS next Y17.87% ROA-22.93% Short Interest0.04M Perf Year40.95%
Cash/sh2.11 P/C1.61 EPS next 5Y- ROE-32.26% 52W Range1.80 - 5.30 Perf YTD-3.22%
Dividend Est.- P/FCF- EPS past 5Y0.14% ROI-29.40% 52W High-35.91% Beta0.49
Dividend TTM- Quick Ratio2.64 Sales past 5Y12.81% Gross Margin47.46% 52W Low88.72% ATR (14)0.51
Dividend Ex-Date- Current Ratio3.99 EPS Y/Y TTM32.75% Oper. Margin-29.00% RSI (14)40.74 Volatility12.90% 14.64%
Employees130 Debt/Eq0.05 Sales Y/Y TTM19.25% Profit Margin-34.11% Recom1.00 Target Price8.00
Option/ShortYes / Yes LT Debt/Eq0.04 EPS Q/Q-45.46% Payout- Rel Volume1.07 Prev Close3.76
Sales Surprise1.04% EPS Surprise-56.25% Sales Q/Q18.31% EarningsMar 04 BMO Avg Volume39.99K Price3.40
SMA20-15.90% SMA50-17.75% SMA2000.62% Trades Volume42,887 Change-9.65%
Date Action Analyst Rating Change Price Target Change
Feb-24-21Initiated SVB Leerink Outperform $20
Mar-05-24 09:11AM
Mar-04-24 07:00AM
Mar-01-24 05:01PM
Feb-26-24 08:00AM
Nov-12-23 09:38AM
07:00AM Loading…
Nov-09-23 07:00AM
Nov-02-23 08:03AM
Aug-09-23 07:00AM
Jul-24-23 07:00AM
May-15-23 07:00AM
May-10-23 08:00AM
Mar-20-23 03:05AM
Mar-16-23 07:00AM
Mar-09-23 08:00AM
Feb-14-23 07:00AM
08:00AM Loading…
Nov-22-22 08:00AM
Nov-09-22 07:00AM
Nov-02-22 08:00AM
Sep-08-22 07:00AM
Aug-16-22 07:00AM
Aug-08-22 07:00AM
Aug-01-22 08:00AM
Jun-13-22 07:00AM
Jun-09-22 07:30AM
May-09-22 07:00AM
May-02-22 08:00AM
Apr-21-22 09:08AM
Mar-03-22 07:00AM
Mar-01-22 07:00AM
Feb-28-22 04:01PM
02:01AM Loading…
Feb-23-22 02:01AM
Feb-10-22 08:00AM
Jan-04-22 08:00AM
Dec-31-21 07:53AM
Nov-16-21 08:00AM
Nov-12-21 07:00AM
Nov-08-21 07:00AM
Nov-01-21 08:00AM
Oct-02-21 10:32AM
Sep-02-21 08:00AM
Aug-16-21 08:00AM
Aug-05-21 07:00AM
Jul-29-21 08:00AM
Jul-15-21 08:00AM
May-24-21 08:00AM
May-05-21 07:00AM
06:45AM
Apr-28-21 08:00AM
Mar-10-21 07:00AM
Mar-03-21 04:05PM
Feb-16-21 01:28PM
Feb-08-21 08:00AM
Feb-01-21 07:00AM
Jan-03-21 03:58AM
Nov-23-20 08:00AM
Nov-11-20 04:01PM
Nov-09-20 04:01PM
Nov-02-20 08:00AM
LENSAR, Inc. engages in the development of femtosecond laser technology for refractive cataract surgery. Its product offers automation and customization options for astigmatism treatment planning and other steps of the refractive cataract surgery procedure. The company was founded by Scott Addyman, Randy W. Frey, and Ronald R. Krueger in 2004 and is headquartered in Orlando, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Winer Gary MDirectorNov 22 '23Buy2.1030063053,345Nov 27 07:30 PM
Winer Gary MDirectorNov 16 '23Buy2.121,0002,12553,045Nov 17 06:18 PM
Winer Gary MDirectorNov 15 '23Buy2.155001,07552,045Nov 17 06:18 PM
Winer Gary MDirectorNov 10 '23Buy2.131,0002,13551,545Nov 14 07:31 PM
Winer Gary MDirectorAug 11 '23Buy3.607052,53850,545Aug 14 07:01 PM
Winer Gary MDirectorAug 10 '23Buy3.661,0003,66049,840Aug 14 07:01 PM
WEISNER AIMEE SDirectorMay 22 '23Buy2.7516,64745,77954,285May 23 04:45 PM
WEISNER AIMEE SDirectorMay 19 '23Buy2.5922,15357,37637,638May 19 06:54 PM
WEISNER AIMEE SDirectorMay 18 '23Buy2.617,70020,09715,485May 19 06:54 PM
WEISNER AIMEE SDirectorMay 17 '23Buy2.293,5008,0157,785May 19 06:54 PM